Wednesday, November 25, 2009, 3:40am EST - Canadian Markets open in 5 hours and 50 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Pressure BioSciences, Inc. (PBIO)

 On Nov 24: 1.675 USD   0.00 (0.00%)  
MORE ON PBIO
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Pressure BioSciences, Inc. (NCM:PBIO) Delayed quote dataEdit
Last Trade: 1.675 USD
Trade Time: Nov 24
Change: 0.00 (0.00%)
Prev Close: 1.675
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 2.50
Day's Range: N/A - N/A
52wk Range: 0.55 - 2.10
Volume: 0
Avg Vol (3m): 7,983.33
Market Cap: 3.68M
P/E (ttm): N/A
EPS (ttm): -1.398
Div & Yield: N/A (N/A%)
Pressure BioSciences, Inc. (PBIO)
1d  5d  3m  6m  1y  2y  5y  max 
 Add PBIO to Portfolio   Download Data

HEADLINES
• PRESSURE BIOSCIENCES INC Financials
EDGAR Online Financials (Sat, Nov 21)
• PRESSURE BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity
EDGAR Online (Thu, Nov 19)
• Chromcraft, pSivida: Midday Volume Plays
at TheStreet.com (Wed, Nov 18)
• PRESSURE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Mon, Nov 16)
• Q3 2009 Pressure BioSciences Earnings Release - Time Not Supplied
CCBN (Mon, Nov 16)
• Q3 2009 Pressure BioSciences Earnings Release - Time Not Supplied
CCBN (Fri, Nov 13)
• BioMed News Bytes: IntelGenx, Pressure BioSciences
at Seeking Alpha (Thu, Oct 15)
• PRESSURE BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
EDGAR Online (Thu, Sep 17)
• PRESSURE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Mon, Aug 10)
• PRESSURE BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, May 15)
• PRESSURE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Tue, May 5)
More Headlines for PBIO...
ANALYST
EPS Est (next year) (Dec-09) : -1.20
EPS Est (in 2 years) (Dec-10) : -1.31
Avg Rec (current)*: 2.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Pressure BioSciences, Inc. (PBI) focuses on the development and commercialization of a novel, enabling technology called Pressure Cycling Technology (PCT).

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices